Business Description
Geron Corporation is a California-based company that develops medicines to treat blood cancers and related conditions. Its lead approved product, RYTELO, targets an enzyme called telomerase and is used to treat a blood disorder known as myelodysplastic syndromes. The company has several additional treatments in various stages of clinical testing, aimed at conditions including myelofibrosis and acute myeloid leukemia. Founded in 1990, Geron continues to build its portfolio of cancer-focused therapies for patients with limited treatment options.
